TrialHaematologica2011
High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.
François Vergez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
109 papers cite itlatest 60 shown
this papertrialcites it